The average one-year price target for GoodRx Holdings (NasdaqGS:GDRX) has been revised to $2.87 / share. This is a decrease ...

Eliquis, also known as apixaban, helps reduce the risk of blood clots and stroke, but many patients face steep pharmacy ...

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses ...

A bipartisan quartet of of senators on Wednesday unveiled legislation to cap the monthly cost of insulin at $35 for patients ...

Glucagon-like peptide-1 (GLP-1) medications are now available as a pill for weight loss, offering another option beyond ...

Are you paying too much for your prescription drugs?

Americans are struggling to pay for their medicines and insurance premiums, with some skipping meals or going without ...

Research shows that C-suites are investing in tech for advancing top strategic initiatives, including building new markets or ...

Daryl Hoskins‘ smile widened as he proudly tugged at his bright yellow polo. Fitting into an old favorite shirt was one of the little victories in his journey to a healthier lifestyle and control of ...

As Mark highlighted, the fourth quarter and full year results reflect both strong growth in our patient affordability ...

At this time, I'd like to welcome everyone to Paysign Inc.'s Fourth Quarter and Full Year 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.